![Jill Biden signals White House resolve on cancer research: “This is the fight of our lives”](https://cdn.cancerletter.com/media/2021/02/47-05-Jill-Biden-web.jpg)
![Jill Biden signals White House resolve on cancer research: “This is the fight of our lives”](https://cdn.cancerletter.com/media/2021/02/47-05-Jill-Biden-web.jpg)
Cover Story
Free
By Matthew Bin Han Ong
Jill Biden stopped by at NCI earlier this week to reaffirm the Bidens' pledge to “fight cancer as we know it”—an early signal that cancer research is near the top of the national agenda at the Biden-Harris White House.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
NCI Trials
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
![NCI Trials](https://cdn.cancerletter.com/media/2019/05/03161630/CTEP.jpg)
NCI Trials for February 2021
The National Cancer Institute approved the following clinical research studies last month.
Trending Stories
- How a Georgetown med school student found her calling in surgery, law, and health equity
- Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Laurie Glimcher to step down as Dana-Farber president and CEO, Benjamin Levine Ebert named successor
- Lei Zheng got his PhD in San Antonio; now he returns as cancer center director at Mays
- As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.” - Huiping Liu discusses mentorship, translational research on the UChicago Cancer Luminaries podcast